BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20238479)

  • 21. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule.
    Lozano JM; González R; Kindelán JM; Rouas-Freiss N; Caballos R; Dausset J; Carosella ED; Peña J
    AIDS; 2002 Feb; 16(3):347-51. PubMed ID: 11834945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
    LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
    FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes.
    Rizzo R; Ferrari D; Melchiorri L; Stignani M; Gulinelli S; Baricordi OR; Di Virgilio F
    J Immunol; 2009 Oct; 183(7):4302-11. PubMed ID: 19748989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection.
    Li H; Zhai N; Wang Z; Song H; Yang Y; Cui A; Li T; Wang G; Niu J; Crispe IN; Su L; Tu Z
    Gut; 2018 Nov; 67(11):2035-2044. PubMed ID: 28899983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
    Pizzato N; Derrien M; Lenfant F
    Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
    Favier B; Lemaoult J; Lesport E; Carosella ED
    FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
    Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
    Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-derived HLA-G1 acquisition by monocytes through trogocytosis: possible functional consequences.
    Umeshappa CS; Xiang J
    Cell Mol Life Sci; 2010 Dec; 67(23):4107-8. PubMed ID: 20976522
    [No Abstract]   [Full Text] [Related]  

  • 29. p40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes.
    Poggi A; Tomasello E; Revello V; Nanni L; Costa P; Moretta L
    Int Immunol; 1997 Sep; 9(9):1271-9. PubMed ID: 9310830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
    Apps R; Gardner L; Sharkey AM; Holmes N; Moffett A
    Eur J Immunol; 2007 Jul; 37(7):1924-37. PubMed ID: 17549736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP.
    Lee N; Geraghty DE
    J Immunol; 2003 Nov; 171(10):5264-71. PubMed ID: 14607927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.
    Jabri B; de Serre NP; Cellier C; Evans K; Gache C; Carvalho C; Mougenot JF; Allez M; Jian R; Desreumaux P; Colombel JF; Matuchansky C; Cugnenc H; Lopez-Botet M; Vivier E; Moretta A; Roberts AI; Ebert EC; Guy-Grand D; Brousse N; Schmitz J; Cerf-Bensussan N
    Gastroenterology; 2000 May; 118(5):867-79. PubMed ID: 10784586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
    Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
    Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA class-I-specific inhibitory receptor in human T lymphocytes: interference with T-cell functions.
    Mingari MC; Ponte M; Vitale C; Schiavetti F; Bellomo R; Bertone S; Nanni L
    Res Immunol; 1997; 148(3):150-5. PubMed ID: 9255865
    [No Abstract]   [Full Text] [Related]  

  • 35. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble HLA-G induces NF-kappaB activation in natural killer cells.
    Zidi I; Guillard C; Carosella ED; Moreau P
    J Physiol Biochem; 2010 Mar; 66(1):39-46. PubMed ID: 20405270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
    Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
    Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.
    Wiendl H; Mitsdoerffer M; Hofmeister V; Wischhusen J; Bornemann A; Meyermann R; Weiss EH; Melms A; Weller M
    J Immunol; 2002 May; 168(9):4772-80. PubMed ID: 11971028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP; Csurhes PA; Pfluger CM; Burrows SR
    BMC Neurol; 2011 Aug; 11():95. PubMed ID: 21810280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization.
    Terrazzano G; Sica M; Gianfrani C; Mazzarella G; Maurano F; De Giulio B; de Saint-Mezard S; Zanzi D; Maiuri L; Londei M; Jabri B; Troncone R; Auricchio S; Zappacosta S; Carbone E
    J Immunol; 2007 Jul; 179(1):372-81. PubMed ID: 17579058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.